Regeneron Pharmaceuticals Intellectual Property Contracts & Agreements

11 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
License Agreement, dated as of August 18, 2020, by and among the Registrant, F. Hoffman-La Roche Ltd, and Genentech, Inc
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Praluent Cross License & Commercialization Agreement, dated as of April 5, 2020, and effective as of April 1, 2020, by and between the Registrant and Sanofi Biotechnology SAS
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Form of License Agreement (Exhibit C to Master Agreement contained in Exhibit 10.4)
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
NON-EXCLUSIVE LICENSE AND PARTIALSETTLEMENT AGREEMENT
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2012
Amendment to the Non-Exclusive License and Material Transfer Agreement dated as of March 30, 2007
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2010
AMENDED AND RESTATED LICENSE AND COLLABORATIONAGREEMENT By and Among AVENTIS PHARMACEUTICALS INC., SANOFI-AVENTIS AMERIQUE DUNORD and REGENERON PHARMACEUTICALS,INC. Dated as of...
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2010
EX-10.2: AMENDED AND RESTATED NON-EXCLUSIVE LICENSE AGREEMENT
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2008
EX-10.1: NON-EXCLUSIVE LICENSE AND MATERIAL TRANSFER AGREEMENT
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2007
EX-10.14: NON EXCLUSIVE LICENSE AND MATERIAL TRANSFER AGREEMENT
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2007
NON-EXCLUSIVE PATENT LICENSE AGREEMENT
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NJ
2003
LICENSE AGREEMENT
License Agreements
Regeneron Pharmaceuticals
Biotechnology
DE
2002